Pyrazoles are synthesized by the reaction of α,β-unsaturated aldehydes with hydrazine and subsequent dehydrogenation. 2075-46-9, formula is C3H3N3O2, Name is 4-Nitro-1H-pyrazole. Substituted pyrazoles are prepared by condensation of 1,3-diketones with hydrazine (Knorr-type reactions). For example, acetylacetone and hydrazine gives 3,5-dimethylpyrazole. Safety of 4-Nitro-1H-pyrazole.
Come, Jon H.;Collier, Philip N.;Henderson, James A.;Pierce, Albert C.;Davies, Robert J.;Le Tiran, Arnaud;O’Dowd, Hardwin;Bandarage, Upul K.;Cao, Jingrong;Deininger, David;Grey, Ron;Krueger, Elaine B.;Lowe, Derek B.;Liang, Jianglin;Liao, Yusheng;Messersmith, David;Nanthakumar, Suganthi;Sizensky, Emmanuelle;Wang, Jian;Xu, Jinwang;Chin, Elaine Y.;Damagnez, Veronique;Doran, John D.;Dworakowski, Wojciech;Griffith, James P.;Jacobs, Marc D.;Khare-Pandit, Suvarna;Mahajan, Sudipta;Moody, Cameron S.;Aronov, Alex M. research published 《 Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)》, the research content is summarized as follows. The lipid kinase phosphoinositide 3-kinase γ (PI3Kγ) has attracted attention as a potential target to treat a variety of autoimmune disorders, including multiple sclerosis, due to its role in immune modulation and microglial activation. By minimizing the number of hydrogen bond donors while targeting a previously uncovered selectivity pocket adjacent to the ATP binding site of PI3Kγ, we discovered a series of azaisoindolinones as selective, brain penetrant inhibitors of PI3Kγ. This ultimately led to the discovery of 16, an orally bioavailable compound that showed efficacy in murine exptl. autoimmune encephalomyelitis (EAE), a preclin. model of multiple sclerosis.
Safety of 4-Nitro-1H-pyrazole, 4-Nitro-1H-pyrazole, also known as 4-Nitropyrazole, is a useful research compound. Its molecular formula is C3H3N3O2 and its molecular weight is 113.08 g/mol. The purity is usually 95%.
4-Nitropyrazole, is a building block for the synthesis of various pharmaceutical compounds, including inhibitors, and therapeutic agents. It can be used for the synthesis of highly selective, brain-penetrant aminopyrazole LRRK2 Inhibitor, as a potentially viable treatment for Parkinson’s disease., 2075-46-9.
Referemce:
Pyrazole – Wikipedia,
Pyrazoles – an overview | ScienceDirect Topics